Sign Up to like & get recommendations! 1
Published in 2018 at "Lasers in Surgery and Medicine"
DOI: 10.1002/lsm.22826
Abstract: Genitourinary syndrome of menopause (GSM) combines the conditions of vulvovaginal atrophy (VVA) and urinary tract dysfunction, which is a result of urethral atrophy. There are several treatment methods available for the management of vulvovaginal symptoms… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Lasers in Surgery and Medicine"
DOI: 10.1002/lsm.23346
Abstract: Genitourinary syndrome of menopause (GSM) is a common condition affecting of most postmenopausal women, which greatly impacks the quality of life,and need to treat. This prospective multicenter cohort study aimed to compare the efficacy and… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "International Urogynecology Journal"
DOI: 10.1007/s00192-019-04051-3
Abstract: Introduction and hypothesisFractional CO2 and vaginal erbium lasers have emerged as potential treatment options for genitourinary syndrome of menopause (GSM) in breast cancer (BC) survivors.MethodsWe conducted a systematic review of the literature to ascertain whether… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Lasers in Medical Science"
DOI: 10.1007/s10103-018-2471-3
Abstract: The composition of vaginal microbiome in menopause and cancer survivor women changes dramatically leading to genitourinary syndrome of menopause (GSM) in up to 70% of patients. Recent reports suggest that laser therapy may be valuable… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2018.12.032
Abstract: Genitourinary syndrome of menopause is defined as the collection of signs and symptoms of the genitourinary tract from menopause, previously known as vulvovaginal atrophy. The Food and Drug Administration has approved select hormonal and nonhormonal… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pharmacological research"
DOI: 10.1016/j.phrs.2020.105360
Abstract: Genitourinary syndrome of menopause (GSM) seriously affects the quality of life of women in this stage and patients with breast cancer, but optimal treatment options as well as risks associated with the complication remain controversial.… read more here.
Sign Up to like & get recommendations! 2
Published in 2020 at "Urology"
DOI: 10.1016/j.urology.2020.05.058
Abstract: OBJECTIVES To review the available data related to the prevention of recurrent urinary tract infection (rUTI) in postmenopausal women with vaginal estrogen preparations and provide the urologic community with the confidence to identify and treat… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2017.1290076
Abstract: Abstract The genitourinary syndrome of menopause (GSM) is a frequent complaint among breast cancer (BC) survivors that lead to an important affection of their quality of life (QoL). Lifestyle measures such as smoking cessation or… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Menopause"
DOI: 10.1097/gme.0000000000001309
Abstract: symptomatic women with GSM, whereas 2% to 5% offered O nly a few years ago, topics such as female sexual health were not commonly discussed, let alone sensitive and personal issues such as vaginal dryness… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Menopause"
DOI: 10.1097/gme.0000000000001714
Abstract: 113 Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 mg estradiol… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Menopause"
DOI: 10.1097/gme.0000000000001922
Abstract: Abstract Objective: This study aims to psychometrically validate the Turkish version of the Vulvovaginal Symptom Questionnaire (VSQ). Methods: Postmenopausal women with and without genitourinary syndrome of menopause (GSM) were included as the target population and… read more here.